American Journal of Infection Control

With over 888,000 deaths since onset of the COVID-19 pandemic,1 the vaccine remains the best preventive tool against SARS-CoV-2, including Delta and Omicron variants. Yet, rates remain suboptimal with 63.9% of the US population fully vaccinated.1

Sepsis caused by central line-associated bloodstream infections (CLABSIs) is a significant complication of central venous access, increasing morbidity, mortality, length of stay, and hospital costs 1–3. Central venous access, on the other hand, is

Under the Spaulding classification (1), endocavitary probes or external probes scanning non-intact skin are considered semi-critical devices and must undergo, at least, high level disinfection between uses. Most disinfection guidelines and

The ongoing COVID-19 pandemic has been a shock to the global and U.S. medical system. While there are established and effective guidelines and procedures for prevention of hospital-acquired infections (HAIs), the impact of the pandemic on these best

As the world continues to address the COVID-19 pandemic, we are presented with the opportunity to take stock of our experience and reflect on the journey ahead. The year 2022 marks an especially auspicious time for APIC as we celebrate the 50th

Antibiotic-resistant bacteria have been detected throughout the world.1-6 Antibiotic-resistant bacterial infections prolong hospitalization and increase mortality more than infections caused by antibiotic-sensitive bacteria.7 The annual number of

Hospital acquired infections (HAI) cost the U.S. healthcare system over $10 billion annually in addition to a predicted societal cost (e.g., lost wages and productivity, out of pocket costs) exceeding $200 billion per year1,2. In addition to the

The COVID-19 pandemic has been problematic for the implementation of traditional nursing education with a rapid transition to distance learning. However, distance learning is difficult for nursing educators as they must provide students with clinical

The COVID-19 pandemic brought many challenges with regard to standard infection prevention practices and the proliferation of multi-drug resistant organisms (MDROs)1; 2. Several outbreaks of MDROs within COVID units have been described in the

The Centers for Disease Control and Prevention of the United States define carbapenem-resistant gram-negative bacteria as enterobacteria non-susceptible to any carbapenem antibiotics (MIC ≥4 mg/L for doripenem, meropenem or imipenem or ≥2 mg/L for